Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Novo Nordisk A/S, Novo Alle, DK-2880, Bagsvaerd, Denmark
Estrofem 2 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. Blue, film-coated, round biconvex tablets, engraved with NOVO 280. Diameter 6 mm. |
Each film-coated tablet contains estradiol 2 mg (as estradiol hemihydrate).
Excipient with known effect: lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
| List of Excipients |
|---|
|
The tablet core contains: Lactose monohydrate Film coating: Hypromellose |
1 × 28 tablets in a calendar dial pack.
The calendar pack with 28 tablets consists of the following 3 parts:
Novo Nordisk A/S, Novo Alle, DK-2880, Bagsvaerd, Denmark
PA0218/050/001
Date of first authorisation: 01 May 1996
Date of last renewal: 01 May 2006
| Drug | Countries | |
|---|---|---|
| ESTROFEM | Austria, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
